|
|
|
40
|
41011
|
ZOMETA 4MG INJ (NVS/COL) ZOLENDRONIC ACID
|
ZOLENDRONIC ACID
|
ZOMETA
|
4MG VIAL
|
C
|
842.68
|
842.68
|
INJECTION
|
0
|
VIAL
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
41011
|
ZOMETA 4MG INJ (NVS) ZOLENDRONIC ACID (C)
|
ZOLENDRONIC ACID
|
ZOMETA
|
4MG VIAL
|
C
|
706.76
|
706.7642
|
VIAL
|
2
|
VIAL
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
BONE RESORPTION INHIBITORS
|
|
|
|
|
42
|
41011
|
ZOMETA 4MG INJ (NVS) ZOLENDRONIC ACID
|
ZOLENDRONIC ACID
|
ZOMETA
|
4MG VIAL
|
C
|
706.76
|
706.76
|
VIAL
|
2
|
VIAL
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2026-04-01
|
|
|
IV
|
6
|
BONE RESORPTION INHIBITORS
|
|
|
|
|
41
|
41016
|
ZOLENDRONIC ACID 4MG INJ (ZUV) (BQ)
|
ZOLENDRONIC ACID
|
ZOLENDRONIC ACID
|
4MG VIAL
|
BQ
|
13.59
|
13.5916
|
VIAL
|
2
|
VIAL
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
INJ
|
6
|
BONE RESORPTION INHIBITORS
|
|
|
|
|
42
|
41016
|
ZOLENDRONIC ACID 4MG INJ (ZUV)
|
ZOLENDRONIC ACID
|
ZOLENDRONIC ACID
|
4MG VIAL
|
BQ
|
8.54
|
8.54
|
VIAL
|
2
|
VIAL
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2026-04-01
|
|
|
INJ
|
0
|
BONE RESORPTION INHIBITORS
|
|
|
|
|
40
|
4101A
|
ZOLENDRONIC ACID 4MG INJ (SLS/AHI)
|
ZOLENDRONIC ACID
|
ZOLENDRONIC ACID
|
4MG VIAL
|
BQ
|
38.95
|
38.95
|
INJECTION
|
0
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2022-03-29
|
|
|
|
41
|
4101A
|
ZOLENDRONIC ACID 4MG INJ (SLS) (BQ)
|
ZOLENDRONIC ACID
|
ZOLENDRONIC ACID
|
4MG VIAL
|
BQ
|
30.42
|
30.418
|
VIAL
|
2
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2024-04-01
|
2024-05-27
|
|
IV
|
6
|
BONE RESORPTION INHIBITORS
|
2024-04-15
|
|
|
|
40
|
4101E
|
ZOLASTA 4MG INJ (INP/AHI) ZOLENDRONIC ACID
|
ZOLENDRONIC ACID
|
ZOLASTA
|
5ML
|
BQ
|
35.07
|
35.07
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
42
|
4101Q
|
ZOLOSTEO 4MG INJ (JLP) ZOLENDRONIC ACID
|
ZOLENDRONIC ACID
|
ZOLOSTEO
|
12X4MG
|
BQ
|
108.73
|
9.06
|
VIAL
|
2
|
VIAL
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9224
|
BONE RESORPTION INHIBITORS
|
2026-04-01
|
|
|
IV
|
0
|
BONE RESORPTION INHIBITORS
|
|